Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,845.00    150.00 (2.24%)
Bid:
6,850.00
Ask:
6,860.00
Spread: 10.00 (0.146%)
Market Cap: £5.05b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Vulcanic Acquisition Agreement Executed

25 Jul 2022 07:30

RNS Number : 5266T
Spirax-Sarco Engineering PLC
25 July 2022
 

 

News Release

 

25th July 2022

 

Acquisition of Vulcanic - Definitive Agreement Executed

Spirax-Sarco Engineering plc, the thermal energy management and niche pumping specialist, announces that it has now signed a binding definitive agreement to acquire the Vulcanic Group of Companies (Vulcanic) from Qualium, a French private equity company, for a consideration of €261.7 million on a cash and debt free basis, subject to customary closing adjustments.

 

Signature of this definitive agreement follows the conclusion of exclusive negotiations announced on 4th July 2022.

 

As previously stated, the transaction will require regulatory approvals in France and Germany. These regulatory approvals and completion are expected during the third quarter of the year.

 

 

 

Enquiries:

Nimesh Patel, Chief Financial Officer

Andrew Guthrie, Head of Investor Relations

Tel: +44 01242 535035

 

 

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both Businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs more than 8,700 people, including almost 2,000 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

 

Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGZGZNLDZGZZM
Date   Source Headline
11th Jun 20144:08 pmRNSHolding(s) in Company
6th Jun 20145:41 pmRNSDirector/PDMR Shareholding
5th Jun 20144:31 pmRNSDirector/PDMR Shareholding
5th Jun 20144:04 pmRNSTotal Voting Rights
29th May 20143:43 pmRNSDirector/PDMR Shareholding
23rd May 20144:29 pmRNSDirector/PDMR Shareholding
21st May 20144:29 pmRNSHolding(s) in Company
20th May 20145:50 pmRNSResult of AGM
20th May 20147:00 amRNSInterim Management Statement
7th May 20144:18 pmRNSTotal Voting Rights
30th Apr 20144:59 pmRNSDirector/PDMR Shareholding
17th Apr 20143:40 pmRNSDirector/PDMR Shareholding
8th Apr 20144:25 pmRNSDirector/PDMR Shareholding
2nd Apr 201411:12 amRNSHolding(s) in Company
24th Mar 20144:28 pmRNSAnnual Financial Report
24th Mar 201410:35 amRNSDirector/PDMR Shareholding
11th Mar 20148:30 amRNSDirectorate Change
6th Mar 20147:00 amRNSFinal Results
25th Feb 20147:30 amRNSChange of Director Details
22nd Jan 201411:04 amRNSNotification of Key Dates
6th Jan 20148:36 amRNSAcquisition
3rd Jan 20144:33 pmRNSTotal Voting Rights
16th Dec 20134:10 pmRNSHolding(s) in Company
16th Dec 20139:30 amRNSChange of Auditor
16th Dec 20138:30 amRNSBoard Succession Changes
11th Dec 20132:59 pmRNSDirector/PDMR Shareholding
10th Dec 20139:00 amRNSDirector Declaration
5th Dec 20134:27 pmRNSTotal Voting Rights
29th Nov 20134:21 pmRNSHolding(s) in Company
27th Nov 20134:20 pmRNSDirector/PDMR Shareholding
18th Nov 201312:36 pmRNSDirector/PDMR Shareholding
14th Nov 20134:28 pmRNSDirector/PDMR Shareholding
7th Nov 20137:00 amRNSInterim Management Statement
5th Nov 20134:24 pmRNSTotal Voting Rights
11th Oct 20139:08 amRNSDirector/PDMR Shareholding
2nd Oct 20132:00 pmRNSTotal Voting Rights
2nd Oct 20139:48 amRNSNotification of Release Date - IMS
23rd Sep 20138:41 amRNSHolding(s) in Company
3rd Sep 20138:56 amRNSTotal Voting Rights
30th Aug 20138:00 amRNSAcquisition
22nd Aug 20133:56 pmRNSHolding(s) in Company
13th Aug 20134:28 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNS2013 Half Year Results
7th Aug 201310:00 amRNSBoard Changes
6th Aug 20134:26 pmRNSTotal Voting Rights
12th Jul 20133:20 pmRNSDates for 2013 Half-Year Results
5th Jul 20135:24 pmRNSDirector/PDMR Shareholding
1st Jul 20133:17 pmRNSTotal Voting Rights
24th Jun 20133:34 pmRNSHolding(s) in Company
31st May 20137:00 amRNSAmendment to Official List

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.